India · Delayed Price · Currency is INR Asston Pharmaceuticals Statistics
Total Valuation
BOM:544445 has a market cap or net worth of INR 726.16 million. The enterprise value is 764.27 million.
| Market Cap | 726.16M |
| Enterprise Value | 764.27M |
Important Dates
The last earnings date was Monday, January 5, 2026.
| Earnings Date | Jan 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:544445 has 8.51 million shares outstanding. The number of shares has increased by 16.68% in one year.
| Current Share Class | 8.51M |
| Shares Outstanding | 8.51M |
| Shares Change (YoY) | +16.68% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 60.24% |
| Owned by Institutions (%) | 7.95% |
| Float | 3.18M |
Valuation Ratios
The trailing PE ratio is 22.68.
| PE Ratio | 22.68 |
| Forward PE | n/a |
| PS Ratio | 2.97 |
| PB Ratio | 1.88 |
| P/TBV Ratio | 1.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 31.09 |
| EV / Sales | 3.12 |
| EV / EBITDA | 12.02 |
| EV / EBIT | 12.26 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.23, with a Debt / Equity ratio of 0.10.
| Current Ratio | 4.23 |
| Quick Ratio | 3.77 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.63 |
| Debt / FCF | n/a |
| Interest Coverage | 9.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.06% |
| Return on Capital Employed (ROCE) | 15.38% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:544445 has paid 8.07 million in taxes.
| Income Tax | 8.07M |
| Effective Tax Rate | 24.72% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 86.11 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 48.60 |
| Average Volume (20 Days) | 13,200 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544445 had revenue of INR 244.84 million and earned 24.58 million in profits. Earnings per share was 3.76.
| Revenue | 244.84M |
| Gross Profit | 112.33M |
| Operating Income | 62.35M |
| Pretax Income | 32.65M |
| Net Income | 24.58M |
| EBITDA | 63.60M |
| EBIT | 62.35M |
| Earnings Per Share (EPS) | 3.76 |
Balance Sheet
The company has 1.80 million in cash and 39.92 million in debt, with a net cash position of -38.12 million or -4.48 per share.
| Cash & Cash Equivalents | 1.80M |
| Total Debt | 39.92M |
| Net Cash | -38.12M |
| Net Cash Per Share | -4.48 |
| Equity (Book Value) | 386.34M |
| Book Value Per Share | 56.82 |
| Working Capital | 288.74M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 45.88%, with operating and profit margins of 25.46% and 10.04%.
| Gross Margin | 45.88% |
| Operating Margin | 25.46% |
| Pretax Margin | 13.34% |
| Profit Margin | 10.04% |
| EBITDA Margin | 25.97% |
| EBIT Margin | 25.46% |
| FCF Margin | n/a |
Dividends & Yields
BOM:544445 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.68% |
| Shareholder Yield | -16.68% |
| Earnings Yield | 3.38% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |